{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:04Z","timestamp":1790742004297,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"DOI":"10.1016\/j.crohns.2013.10.006","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T06:15:31Z","timestamp":1384236931000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Differences in the management of pediatric and adult onset ulcerative colitis \u2014 lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis"],"prefix":"10.1093","volume":"8","author":[{"given":"Frank M.","family":"Ruemmele","sequence":"first","affiliation":[{"name":"Universit\u00e9 Sorbonne Paris Cit\u00e9, Paris Descartes, Paris, France"},{"name":"APHP, H\u00f4pital Necker Enfants Malades, Service de Gastroent\u00e9rologie, Pediatric IBD Program, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,1]]},"reference":[{"key":"key\n\t\t\t\t2018110508352899300_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","article-title":"Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry","volume":"19","author":"Levine","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0010","first-page":"137","article-title":"Is pediatric IBD treatment different than in adults?","volume":"58","author":"Lev-Tzion","year":"2012","journal-title":"Minerva Gastroenterol Dietol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease","volume":"135","author":"Van Limbergen","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508352899300_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/gut.2007.136481","article-title":"Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy","volume":"57","author":"Turner","year":"2008","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508352899300_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","article-title":"Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression","volume":"5","author":"Turner","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ibd.21383","article-title":"Acute severe ulcerative colitis in children: a systematic review","volume":"17","author":"Turner","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0040","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/ajg.2009.177","article-title":"The natural history of pediatric ulcerative colitis: a population-based cohort study","volume":"104","author":"Gower-Rousseau","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CEG.S44700","article-title":"The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period","volume":"6","author":"Malaty","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0050","first-page":"2034","article-title":"Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis","volume":"88","author":"Markowitz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005176-200401000-00015","article-title":"Endoscopic rectal sparing in children with untreated ulcerative colitis","volume":"38","author":"Rajwal","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110508352899300_bb0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case\u2013control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"key\n\t\t\t\t2018110508352899300_bb0065","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MIB.0b013e3182802b57","article-title":"Rates and predictors of oral medication adherence in pediatric patients with IBD","volume":"19","author":"LeLeiko","year":"-. 2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"key\n\t\t\t\t2018110508352899300_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","article-title":"Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines","volume":"55","author":"Turner","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"key\n\t\t\t\t2018110508352899300_bb0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1155\/2007\/862917","article-title":"Delayed-release oral mesalamine 4.8 g\/day (800 mg tablets) compared to 2.4 g\/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: the ASCEND I trial","volume":"21","author":"Hanauer","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0080","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/j.1572-0241.2005.00248.x","article-title":"Delayed-release oral mesalamine at 4.8 g\/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial","volume":"100","author":"Hanauer","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"key\n\t\t\t\t2018110508352899300_bb0085","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1053\/j.gastro.2009.08.069","article-title":"Delayed-release oral mesalamine 4.8 g\/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis","volume":"137","author":"Sandborn","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508352899300_bb0090","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.crohns.2013.03.007","article-title":"Presenting features and disease course of pediatric ulcerative colitis","volume":"7","author":"Aloi","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2007.11.001","article-title":"European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis","volume":"2","author":"Stange","year":"2008","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110508352899300_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508352899300_bb0110","doi-asserted-by":"crossref","first-page":"CD000478","DOI":"10.1002\/14651858.CD000478.pub2","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","volume-title":"Cochrane Database Syst Rev","author":"Cochrane Timmer","year":"2007"},{"key":"key\n\t\t\t\t2018110508352899300_bb0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ajg.2010.493","article-title":"Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study","volume":"106","author":"Hyams","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0b013e31818cf555","article-title":"Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?","volume":"48","author":"Cucchiara","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110508352899300_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110508352899300_bb0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/gut.2009.181982","article-title":"Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle","volume":"58","author":"Sokol","year":"2009","journal-title":"Gut"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613003577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613003577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/1\/1\/26359690\/8-1-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T11:38:05Z","timestamp":1564659485000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/8\/1\/1\/1820599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,1]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.10.006","relation":{},"ISSN":["1876-4479","1873-9946"],"issn-type":[{"value":"1876-4479","type":"electronic"},{"value":"1873-9946","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,1]]},"published":{"date-parts":[[2014,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the management of pediatric and adult onset ulcerative colitis \u2014 lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}